Literature DB >> 12105848

RhoA inactivation inhibits cell migration but does not mediate the effects of polyamine depletion.

Ramesh M Ray1, Anami Patel, Mary Jane Viar, Shirley A McCormack, Yi Zheng, Gabor Tigyi, Leonard R Johnson.   

Abstract

BACKGROUND & AIMS: Inhibition of RhoA activity and depletion of polyamines inhibits cell migration and causes changes in the actin cytoskeleton. In this article we have examined the effect of polyamine depletion on RhoA and evaluated these effects on cell migration.
METHODS: Polyamines were depleted in intestinal epithelial cell (IEC)-6 cells by incubating them for 4 days with 5 mmol/L alpha-difluoromethylornithine (DFMO), which inhibits ornithine decarboxylase, the first rate-limiting enzyme in the synthesis of polyamines. IEC-6 cells were then transfected with vectors containing HA tags and constitutively active (HA-V14) or dominant-negative (HA-N19) RhoA with pcDNA3 (vector).
RESULTS: DFMO caused a significant decrease in Rho levels in the cytoplasm and membranes of IEC-6 cells. This decrease was caused by an approximate 50% inhibition of RhoA protein synthesis. Neither the half-life of RhoA nor the level of RhoA messenger RNA (mRNA) was affected. HA-V14-RhoA cells migrated much more rapidly than vector-transfected cells, and HA-N19-RhoA cells exhibited almost no motility. The migration of HA-V14-RhoA cells, however, was inhibited markedly by polyamine depletion. Polyamine depletion did not affect the activity of RhoA in HA-V14-RhoA cells, but inhibited it dramatically in the vector-transfected cells. In the presence of DFMO, the HA-V14-RhoA cells lost stress fibers and gained the appearance of HA-N19-RhoA cells or wild-type cells treated with DFMO.
CONCLUSIONS: First, polyamines are essential for the activity and synthesis and, therefore, normal levels of RhoA protein. Second, RhoA does not mediate the inhibitory effects of polyamine depletion on cell migration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105848     DOI: 10.1053/gast.2002.34216

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.

Authors:  Angelica Belo; Kunrong Cheng; Ahmed Chahdi; Jasleen Shant; Guofeng Xie; Sandeep Khurana; Jean-Pierre Raufman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-27       Impact factor: 4.052

2.  Activation of Dbl restores migration in polyamine-depleted intestinal epithelial cells via Rho-GTPases.

Authors:  Ramesh M Ray; Mitulkumar N Bavaria; Sujoy Bhattacharya; Leonard R Johnson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-03       Impact factor: 4.052

3.  The phosphorylation state of MRLC is polyamine dependent in intestinal epithelial cells.

Authors:  Mitulkumar N Bavaria; Ramesh M Ray; Leonard R Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-10       Impact factor: 4.249

Review 4.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

5.  Basic helix-loop-helix protein E47-mediated p21Waf1/Cip1 gene expression regulates apoptosis of intestinal epithelial cells.

Authors:  Sujoy Bhattacharya; Huazhang Guo; Ramesh M Ray; Leonard R Johnson
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

6.  Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma.

Authors:  Waseem Lone; Alyssa Bouska; Sunandini Sharma; Catalina Amador; Mallick Saumyaranjan; Tyler A Herek; Tayla B Heavican; Jiayu Yu; Soon Thye Lim; Choon Kiat Ong; Graham W Slack; Kerry J Savage; Andreas Rosenwald; German Ott; James R Cook; Andrew L Feldman; Lisa M Rimsza; Timothy W McKeithan; Timothy C Greiner; Dennis D Weisenburger; Federica Melle; Giovanna Motta; Stefano Pileri; Julie M Vose; Wing C Chan; Javeed Iqbal
Journal:  Clin Cancer Res       Date:  2021-08-23       Impact factor: 13.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.